跳至主要内容
临床试验/JPRN-UMIN000008017
JPRN-UMIN000008017已完成2 期

Clinical study to investigate the efficacy of rituximab monotherapy after the rituximab combination chemotherapy for previously untreated follicular lymphoma<THF019> - Clinical study to investigate the efficacy of rituximab monotherapy after the rituximab combination chemotherapy for previously untreated follicular lymphoma<THF019>

TOHOKU HEMATOLOGY FORUM0 个研究点目标入组 24 人开始时间: 2012年5月23日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)active double cancer 2)severe infection or severe complication 3)having prior drug allergy 4)prior treated heart failure or renal failure 5)Cirrhosis of the liver 6)HBs-Ag positive 7)Disorder of electrocardiogram, Disorder of heart fanction, severe heart disease 8)pregnant/lactating woman 9)psychosis 10)given systemic steroid 11)Physician's decision of inappropriateness

研究者

发起方
TOHOKU HEMATOLOGY FORUM

相似试验

Clinical study to investigate the efficacy of... | 临床试验